Research Article
Correlation Analysis of Pathological Features and Axillary Lymph Node Metastasis in Patients with Invasive Breast Cancer
Table 4
Comparison of pathological features between two groups [cases, (%)].
| | Index | ALNM group ( =40) | NALNM group ( =82) | | value |
| | HER-2 (, %) | | | 2.325 | 0.508 | | (-) | 6 (15.00%) | 16 (19.51%) | | | | (1+) | 7 (17.50%) | 21 (25.61%) | | | | (2+) | 19 (47.50%) | 35 (42.68%) | | | | (3+) | 8 (20.00%) | 10 (12.20%) | | | | Ki-67 (, %) | | | 0.822 | 0.365 | | Positive | 34 (85.00%) | 64 (78.05%) | | | | Negative | 6 (15.00%) | 18 (21.95%) | | | | ER (, %) | | | 1.069 | 0.301 | | Positive | 30 (75.00%) | 68 (82.93%) | | | | Negative | 10 (25.00%) | 14 (17.07%) | | | | PR (, %) | | | 0.467 | 0.494 | | Positive | 32 (80.00%) | 61 (74.39%) | | | | Negative | | | | | | Supraclavicular LNM (, %) | 1 (2.50%) | 0 (0.00%) | 0.136 | 0.713 | | Invade the skin or chest wall (, %) | 1 (2.50%) | 1 (1.22%) | 0.056 | 0.813 | | Pathological types (, %) | | | 0.880 | 0.348 | | Special type | 5 (12.50%) | 6 (7.32%) | | | | Non-special type | 35 (87.50%) | 76 (92.68%) | | | | LVI (, %) | 15 (37.50%) | 5 (6.10%) | 19.343 | 0.000 |
|
|
ALNM: axillary lymph node metastasis; NALNM: non-axillary lymph node metastasis; HER-2: human epidermal growth factor receptor 2; ER: estrogen receptor; PR: progestogen receptor; LNM: lymph node metastasis; LVI: lymphovascular invasion.
|
